Lv5
1540 积分 2022-06-14 加入
Resistance to KRAS G12C Inhibition in Non-small Cell Lung Cancer
29天前
已完结
Structure-Based Design of New LSD1/EGFRL858R/T790M Dual Inhibitors for Treating EGFR Mutant NSCLC Cancers
1个月前
已完结
A Comprehensive Review of Targeting RAF Kinase in Cancer Targeting RAF Kinase in Cancer
4个月前
已完结
Epidermal growth factor receptor mutations in breast Cancer: Therapeutic challenges and way forward
4个月前
已完结
Sunvozertinib monotherapy in EGFR tyrosine kinase Inhibitor-Resistant Non-Small cell lung cancer with EGFR mutations
4个月前
已完结
Three new disease-progression modes in NSCLC patients after EGFR-TKI treatment by next-generation sequencing analysis
4个月前
已完结
Gedatolisib in combination with palbociclib and endocrine therapy in women with hormone receptor-positive, HER2-negative advanced breast cancer: results from the dose expansion groups of an open-label, phase 1b study
4个月前
已完结
Safety, Efficacy and Biomarker Analysis of Crizotinib in MET Mutated Non-Small Cell Lung Cancer – Results from the Drug Rediscovery Protocol
4个月前
已完结
Sunvozertinib monotherapy in EGFR tyrosine kinase Inhibitor-Resistant Non-Small cell lung cancer with EGFR mutations
4个月前
已完结
Overcoming tyrosine kinase inhibitor resistance in lung cancer brain metastasis with CTLA4 blockade
5个月前
已完结
皖公网安备34019202002308
